DeepMed Research

University of California, Los Angeles

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1919-05-23

Employees: 10K

Market Cap: -

Website: http://www.ucla.edu

Clinical Trials

Memory Training Versus Yogic Meditation Training in Older Adults With Mild Cognitive Impairment

Not Applicable

Completed

Conditions: Mild Cognitive Impairment

Interventions: Behavioral: Kundalini yoga and meditation
Behavioral: Memory Training

First Posted Date: 2013-11-14

Last Posted Date: 2018-10-23

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 81

Registration Number: NCT01983930

Locations: 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States

Testing the Use of Prompts to Increase Adolescent Immunization Rates

Not Applicable

Completed

Conditions: Vaccine Preventable Diseases
Meningococcal Disease
Pertussis
Human Papillomavirus
Influenza

Interventions: Other: Point-of-Care Prompt

First Posted Date: 2013-11-14

Last Posted Date: 2017-05-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 7040

Registration Number: NCT01984125

Locations: 🇺🇸
Mendon Pediatrics, Mendon, New York, United States
🇺🇸
Oak Orchard Community Health Center, Brockport, New York, United States
🇺🇸
St. Louis University - School of Medicine, Saint Louis, Missouri, United States

and more 19 locations

Mobile Application to Enhance Diabetic Care

Not Applicable

Withdrawn

Conditions: Diabetes Mellitus

Interventions: Behavioral: Diabetes Mobile Application

First Posted Date: 2013-11-14

Last Posted Date: 2016-05-12

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT01983917

Locations: 🇺🇸
Jules Stein Eye Institute, Los Angeles, California, United States

Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary Hypertension

Not Applicable

Withdrawn

Conditions: Congenital Heart Disease

Interventions: Drug: Remodulin

First Posted Date: 2013-11-11

Last Posted Date: 2017-09-21

Lead Sponsor: University of California, Los Angeles

Registration Number: NCT01980979

Locations: 🇺🇸
UCLA Medical Center, Los Angeles, California, United States
🇺🇸
Ohio State University/Nationwide Children's Hospital, Columbus, Ohio, United States

Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial

Phase 2

Completed

Conditions: Autism Spectrum Disorder

Interventions: Drug: AZD7325
Drug: Placebo

First Posted Date: 2013-10-21

Last Posted Date: 2015-10-22

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 40

Registration Number: NCT01966679

Locations: 🇺🇸
Seattle Children's Research Institute, Seattle, Washington, United States
🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

Whole Coffee Fruit Concentrate Pilot Study 1

Not Applicable

Completed

Conditions: Affect
Cognitive Function
Brain-derived Neurotrophic Factor (BDNF)

Interventions: Dietary Supplement: Nutrim
Dietary Supplement: Whole Coffee Fruit Concentrate (WCFC)

First Posted Date: 2013-10-18

Last Posted Date: 2015-01-19

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 39

Registration Number: NCT01965795

Locations: 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States

Effect of Walnuts on Sperm Parameters and Male Fertility

Not Applicable

Completed

Conditions: Teratozoospermia
Asthenozoospermia
Oligozoospermia
Fertility

Interventions: Dietary Supplement: Walnuts
Dietary Supplement: OTC multivitamin

First Posted Date: 2013-10-01

Last Posted Date: 2020-12-01

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 80

Registration Number: NCT01954498

Locations: 🇺🇸
Male Reproductive Medicine and Microsurgery Clinic, Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸
University of California Los Angeles, Los Angeles, California, United States

Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309)

Phase 4

Completed

Conditions: Renal Transplant Rejection

Interventions: Drug: Belatacept

First Posted Date: 2013-09-30

Last Posted Date: 2022-12-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 20

Registration Number: NCT01953120

Locations: 🇺🇸
UCLA Kidney Transplant Research, Los Angeles, California, United States

Pomegranate Extract and Memory

Phase 2

Completed

Conditions: Healthy Volunteers

Interventions: Other: Placebo
Dietary Supplement: POMx

First Posted Date: 2013-09-25

Last Posted Date: 2020-03-02

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 212

Registration Number: NCT01950221

Locations: 🇺🇸
UCLA Longevity Center, Los Angeles, California, United States

Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels

Not Applicable

Completed

Conditions: Pre-diabetic

Interventions: Dietary Supplement: Sugar Pill
Dietary Supplement: XOS 2.8

First Posted Date: 2013-09-18

Last Posted Date: 2017-03-01

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 18

Registration Number: NCT01944904

Locations: 🇺🇸
UCLA Center for Human Nutrition, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy